STOCK TITAN

Adage's 8.4M-Share Holding in CNTA Reported on Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Adage Capital Management, together with principals Robert Atchinson and Phillip Gross, reports beneficial ownership of 8,403,000 ordinary shares of Centessa Pharmaceuticals, representing 6.29% of the outstanding class based on 133,618,774 shares. The shares are ordinary shares underlying ADSs traded under ticker CNTA. The filing shows no sole voting or dispositive power — all voting and dispositive rights are reported as shared — and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing control. The statement contains ownership details and reporting person roles but does not disclose any transaction terms or plans.

Positive

  • Adage Capital and named principals beneficially own 8,403,000 shares, representing a material 6.29% stake in Centessa.
  • The filing includes a certification that the holdings were acquired and are held in the ordinary course of business and not to change control.

Negative

  • No sole voting or dispositive power is reported; all 8,403,000 shares are disclosed as subject to shared voting and dispositive authority.

Insights

TL;DR Institutional stake of 6.29% is materially sized but reported with shared control and no stated intent to change control.

Adage Capital and the named principals report beneficial ownership of 8,403,000 shares, equal to 6.29% of the class, calculated on an outstanding base of 133,618,774 shares. For investors, a >5% disclosure is material because it signals a meaningful economic position, but the filing also makes clear that voting and dispositive powers are shared and the holders certify the position is not intended to effect control. Absent additional transactions or statements of intent, this remains a disclosure of ownership rather than an activist or control move.

TL;DR The filing documents a sizeable passive stake with shared voting/dispositive power and an explicit certification against control-seeking.

The Schedule 13G/A identifies Adage Capital Management as the reporting entity and names Robert Atchinson and Phillip Gross as related reporting persons with managerial roles in the reporting structure. All 8,403,000 shares are reported with shared voting and dispositive authority, and the signatory certification states the securities are held in the ordinary course and not to influence control. From a governance perspective, the filing increases transparency about substantial ownership while signaling an absence of immediate governance actions or control initiatives.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Adage Capital Management, L.P.
Signature:/s/ Robert Atchinson
Name/Title:By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Date:08/12/2025
Robert Atchinson
Signature:/s/ Robert Atchinson
Name/Title:Robert Atchinson, individually
Date:08/12/2025
Phillip Gross
Signature:/s/ Phillip Gross
Name/Title:Phillip Gross, individually
Date:08/12/2025

FAQ

How many Centessa (CNTA) shares does Adage Capital report owning?

The filing reports 8,403,000 ordinary shares beneficially owned by Adage Capital and the named reporting persons.

What percentage of CNTA does the reported stake represent?

The reported position represents 6.29% of the outstanding ordinary shares, based on 133,618,774 shares outstanding.

Does Adage Capital claim voting or dispositive control over the CNTA shares?

No. The filing shows 0 sole voting power and 0 sole dispositive power, with 8,403,000 shares reported as shared voting and dispositive power.

Are the Centessa shares held to seek control according to the filing?

The certification in the filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Under what structure are the shares held by the reporting persons?

The statement indicates the position is held by Adage Capital Management as investment manager with related reporting persons described in management roles; specific ownership is reported on behalf of the investment entities named in the filing.

Are the reported shares ordinary shares or ADSs for CNTA?

The filing clarifies the reported holdings are ordinary shares underlying American Depositary Shares (ADSs) that trade under ticker CNTA.
Centessa Pharmaceuticals Plc

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Latest SEC Filings

CNTA Stock Data

3.39B
133.70M
0.49%
93.69%
3.93%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
ALTRINCHAM, CHESHIRE